Global Leaders Group (GLG) on Antimicrobial Resistance (AMR) released a report “Towards Specific Commitments and Action in Response to AMR” | Current Affairs | Vision IAS
News Today Logo

Global Leaders Group (GLG) on Antimicrobial Resistance (AMR) released a report “Towards Specific Commitments and Action in Response to AMR”

Posted 09 Apr 2024

2 min read

  • Report aims to inform outcomes of the 2024 United Nations General Assembly High-level Meeting on AMR, to be held in September 2024. 

 

  • Recommendations for consideration by UNGA meeting on AMR:
    • Convene an Independent Panel on Evidence for Action against Antimicrobial Resistance by 2025, in a One Health context. 
    • Expansion of existing financing instruments such as Green Climate Fund, Global Environment Facility to include AMR.
    • Quadripartite organizations (FAO, UNEP, WHO, WOAH) should urgently update the 2015 Global Action Plan on AMR to ensure One Health response.
    • Report quality assured AMR surveillance data through global surveillance systems (GLASS, ANIMUSE and InFARM).

 

  • Proposed targets (to be achieved by 2030): 
    • Reduction in global deaths caused by bacterial AMR by 10%. 
    • Access group antibiotics comprise at least 80% of overall human antibiotic consumption
      • Access group is one of the groups under WHO AWaRE classification along with Watch and Reserve Groups.
    • Reduce quantity of antimicrobial used in agri-food system globally by at least 30-5-% from current level. 

 

  • GLG on AMR was established in 2020 following the recommendation of the Interagency Coordination Group on AMR (IACG) to advocate for political action for mitigation of drug-resistant infections.

 

Escalating impact of AMR:

  • Leading cause of death globally and will reduce life expectancy globally by 1.8 years by 2035.
  • Compromising food security due to impact on livestock production and global food chain
  • AMR is closely linked to triple planetary crisis of climate, biodiversity loss, and pollution and waste.
  • Greater health expenditures with treatment expenses reaching US$ 412 billion annually up to 2035.
  • Tags :
  • WHO AWaRe
  • UNGA
  • Antimicrobial Resistance
  • Antibiotics
Watch News Today